Page last updated: 2024-09-03

sch 34826 and Hypertension

sch 34826 has been researched along with Hypertension in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cigola, E; Monopoli, A; Olivetti, G; Ongini, E	1
Crozier, IG; Espiner, EA; Frampton, C; Ikram, H; Kosoglou, T; Rallings, M; Richards, AM; Yandle, TG	1
Chen, YF; Esunge, P; Jin, H; Mathews, C; Oparil, S; Wyss, JM; Yang, R	1
Brown, A; Chiu, PJ; Griscti, K; Sybertz, EJ; Vemulapalli, S	1
Sybertz, EJ	1
Chiu, PJ; Sybertz, EJ; Vemulapalli, S; Watkins, RW	2
Forlani, A; Monopoli, A; Ongini, E	1
Chiu, PJ; Haslanger, MF; Sybertz, EJ; Vemulapalli, S; Watkins, R	1

Reviews

1 review(s) available for sch 34826 and Hypertension

Article	Year
SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator. Clinical nephrology, 1991, Volume: 36, Issue:4 Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Dioxolanes; Dipeptides; Drug Synergism; Heart Failure; Humans; Hypertension; Neprilysin; Prodrugs; Rats	1991

Trials

1 trial(s) available for sch 34826 and Hypertension

Article	Year
Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure. Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:5 Topics: Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dioxolanes; Dipeptides; Double-Blind Method; Epinephrine; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuresis; Neprilysin; Norepinephrine; Renin-Angiotensin System	1992

Article

Year

Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.

Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:5

Topics: Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dioxolanes; Dipeptides; Double-Blind Method; Epinephrine; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuresis; Neprilysin; Norepinephrine; Renin-Angiotensin System

1992

Other Studies

7 other study(ies) available for sch 34826 and Hypertension

Article	Year
The neutral endopeptidase inhibitor, SCH 34826, reduces left ventricular hypertrophy in spontaneously hypertensive rats. Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:3 Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Dioxolanes; Dipeptides; Hemodynamics; Hypertension; Male; Microscopy, Electron; Myocardium; Neprilysin; Rats; Rats, Inbred SHR; Ventricular Function, Left	1992
Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats. American journal of hypertension, 1992, Volume: 5, Issue:4 Pt 1 Topics: Administration, Oral; Analgesics; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dioxolanes; Dipeptides; Hypertension; Male; Protease Inhibitors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium; Sodium Chloride	1992
The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats. Life sciences, 1991, Volume: 49, Issue:5 Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Desoxycorticosterone; Dioxolanes; Dipeptides; Hypertension; Kidney; Male; Neprilysin; Peptide Fragments; Rats	1991
Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action. Canadian journal of physiology and pharmacology, 1991, Volume: 69, Issue:10 Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Drug Synergism; Hypertension; Iodine Radioisotopes; Kinins; Male; Metalloendopeptidases; Rats; Rats, Inbred Strains; Thiorphan	1991
Chronic inhibition of neutral endopeptidase reduces left ventricular hypertrophy without changing blood pressure in spontaneously hypertensive rats. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Dioxolanes; Dipeptides; Enalapril; Hypertension; Methionine; Myocardium; Neprilysin; Rats; Rats, Inbred SHR	1991
Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:7 Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Bradykinin; Desoxycorticosterone; Dioxolanes; Dipeptides; Hypertension; Male; Methionine; Neprilysin; Rats; Rats, Inbred Strains; Sodium, Dietary	1990
Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor. Hypertension (Dallas, Tex. : 1979), 1990, Volume: 15, Issue:2 Topics: Administration, Oral; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dioxolanes; Dioxoles; Dipeptides; Drug Synergism; Hemodynamics; Hypertension; Kidney; Male; Neprilysin; Rats; Rats, Inbred SHR	1990